Arizona Biosciences News


Heliae-breaking
Jan 31, 2012

Arizona Bioscience Sector Sustains Strong Job Growth

Neither the recession nor the subsequent economic doldrums have impeded growth of Arizona’s bioscience sector, a new report shows. During the post-recessionary period of 2009-10, bioscience jobs increased by 7.4 percent, compared to a 1.8 percent drop for the state’s overall private sector, according to an analysis of Arizona biosciences, commissioned by the Flinn Foundation. 

Suggest_a_story_button
Feb, 17, 2012
C-Path announces hiring of new president and CEO Carolyn Compton
Compton__carolyn_-_hz-thumb

Carolyn Compton, an internationally recognized cancer pathologist who previously led important units at the National Institutes of Health, has been hired as the new president and CEO of the Tucson-based Critical Path Institute. Dr. Compton replaces Raymond Woosley, a longtime fixture in Arizona's bioscience community, who founded C-Path in 2005 to help make development of health-care innovations safer, faster, and cheaper. 

Feb, 16, 2012
Biozona Weekly: Science standards critiqued; Chandler incubator expanding; Ulthera secures ACA support

Top bioscience news, February 9-16: The Thomas B. Fordham Institute's assessment of science standards nationwide finds little to praise in Arizona's standards. ¶ Chandler's Innovations tech incubator will expand its facility by more than 50% ¶ Medical-device maker Ulthera has received funding from the Arizona Commerce Authority and plans to expand its Mesa presence. (Plus 3 more stories.)

Feb, 07, 2012
Biozona Weekly: Bio Roadmap update; canine cancer research; much more

Top bioscience news, January 24-February 7: Bioscience Roadmap update shows sharp increase in jobs ¶ TGen's canine research provides insights into human cancer ¶ Carolyn Compton assumes C-Path leadership (Plus 10 more stories.)

Jan, 17, 2012
New Phoenix mayor signals emphasis on biosciences
Stanton__greg_hz-thumb

Greg Stanton, the newly elected mayor of Phoenix, began his tenure on January 3 with a strong show of commitment to the bioscience sector, announcing a plan to develop a bioscience cluster around the Mayo Clinic hospital campus in north Phoenix and reaffirming his support for the University of Arizona College of Medicine-Phoenix. 

Jan, 11, 2012
Arizona-centric "Dream Team" targets melanoma
Trent__jeffrey_hz-thumb

A partnership of nearly 50 scientists, led by Jeffrey Trent, president and research director of the Phoenix-based Translational Genomics Research Institute, has won a highly competitive $6 million grant to find new ways to stop melanoma, the most dangerous kind of skin cancer. Researchers from Arizona State University and Mayo Clinic Arizona are also playing key roles for the project, which is funded by Stand Up To Cancer and the Melanoma Research Alliance. 

Oct, 21, 2011
Flinn Foundation Announces Grant for First-Annual Arizona Science and Technology Festival
Science_festival-hz2b-thumb

The Flinn Foundation has announced its support for the inaugural Arizona Science and Technology (SciTech) Festival, a six-week event in cities and towns across Arizona that will showcase innovation in science, technology, engineering, and mathematics (STEM). The Festival’s events will be centered in February 2012, coinciding with the celebration of Arizona’s centennial.